Imaging Cancer
- đ¤ Speaker: Dr Kevin Brindle, Cancer Research Institute/Dept. Biochemistry, University of Cambridge
- đ Date & Time: Tuesday 16 February 2010, 19:30 - 21:00
- đ Venue: Wolfson Lecture Theatre, Churchill College, Storey's Way, Cambridge
Abstract
Patients with similar tumour types can have markedly different responses to the same therapy. The development of new treatments would benefit significantly from the introduction of imaging methods that allow an early assessment of treatment response in individual patients, allowing rapid selection of the most effective treatment.
We have been developing non-invasive and clinically applicable magnetic resonance-based methods for detecting the early responses of tumours to therapy. Primarily, these are methods for detecting tumour cell death; the level of tumour cell death following drug treatment is a good predictive indicator for treatment outcome. By monitoring tumour cell death we may get an indication of whether a particular drug is working very early during treatment, possibly within 24-48 hours, and long before there is any evidence of tumour shrinkage
Series This talk is part of the Cambridge Society for the Application of Research (CSAR) series.
Included in Lists
- All Talks (aka the CURE list)
- Biology
- Cambridge Energy Seminars
- CamBridgeSens
- Cambridge Society for the Application of Research (CSAR)
- Cambridge talks
- Centre for Health Leadership and Enterprise
- Chris Davis' list
- custom
- Featured lists
- Featured talks
- Guy Emerson's list
- history
- Life Science Interface Seminars
- Life Sciences
- Life Sciences
- Major Public Lectures in Cambridge
- ME Seminar
- my_list
- NanoDTC Energy Materials Talks
- Neurons, Fake News, DNA and your iPhone: The Mathematics of Information
- other talks
- personal list
- Trust & Technology Initiative - interesting events
- Wolfson Lecture Theatre, Churchill College, Storey's Way, Cambridge
- yk373's list
- yk449
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Dr Kevin Brindle, Cancer Research Institute/Dept. Biochemistry, University of Cambridge
Tuesday 16 February 2010, 19:30-21:00